Walleye Trading
GPCR icon

Walleye Trading’s Structure Therapeutics GPCR Stock Holding History

Walleye Trading’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$221K Buy
+4,113
New +$182K ﹤0.01% 3079
2025
Q1 		– Sell
-13,485
Closed -$330K – 4296
2024
Q4 		$366K Buy
13,485
+4,909
+57% +$174K ﹤0.01% 2840
2024
Q3 		$376K Buy
+8,576
New +$332K ﹤0.01% 2692
2024
Q1 		– Sell
-13,879
Closed -$585K – 4992
2023
Q4 		$566K Buy
+13,879
New +$795K ﹤0.01% 2974

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Walleye Trading's GPCR Position: Q2 2026 in Review

Walleye Trading opened a new position in Structure Therapeutics (GPCR) in Q2 2026: 4,113 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #3079 among its holdings. This is a return to the name: Walleye Trading previously reported a position in GPCR as recently as Q4 2024.

Walleye Trading first reported a position in GPCR in Q4 2023 and has held it in 4 quarters since. The position peaked at $566K in Q4 2023. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Walleye Trading held 4,113 shares of Structure Therapeutics worth $221K as of Q2 2026.
  • Structure Therapeutics was a new Walleye Trading position in Q2 2026.
  • Structure Therapeutics made up ﹤0.01% of Walleye Trading's portfolio in Q2 2026, its #3079 holding.
  • Walleye Trading first reported a position in Structure Therapeutics in Q4 2023 and has held it in 4 quarters since.
  • Walleye Trading's Structure Therapeutics position peaked at $566K in Q4 2023.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.